Dermatology Compensation Guide by Practice Type
Understanding how compensation models work in dermatology is an important component of a successful job search. What variables turn a “good” offer into a “great” offer? The goal of this article is to discuss some of the different compensation models that exist to help you find the right fit for your career.
Fixed compensation models
There are three types of fixed compensation models: …
Understanding how compensation models work in dermatology is an important component of a successful job search. What variables turn a “good” offer into a “great” offer? The goal of this article is to discuss some of the different compensation models that exist to help you find the right fit for your career.
Fixed compensation models
There are three types of fixed compensation models: … Continue reading "Dermatology Compensation Guide by Practice Type"
Chronic urticaria is a common dermatologic condition, yet according to a recent survey, one in five clinicians deviates from known management guidelines. Researchers at the George Washington University (GWU) School of Medicine and Health Sciences Department of Dermatology surmised that the lack of confidence in workup and management of chronic urticaria and lack of adherence to guidelines may stem … 
Hair loss visits are common but, if you’re like me, it can still give pause in a busy clinic. During a session titled Strands of Clarity: Mastering the Hair & Scalp Exam at the ODAC Dermatology conference, Dr. Ronda Farah— nationally and internationally recognized in hair loss and serving as an Associate Professor in the Department of Dermatology at the University of Minnesota—focused on … 
5-aminolevulinic acid (5-ALA) is an FDA-approved prodrug used in combination with light therapy for treatment of actinic keratosis and superficial basal cell carcinoma. It is a naturally occurring amino acid that is an intermediate of the heme biosynthesis pathway which cells convert into the photosensitizing metabolite protoporphyrin IX (PpIX). This compound has been applicable in two specific cl … 
The FDA’s approval of delgocitinib for chronic hand eczema is shining a light on this and other regional eczemas. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Peter A. Lio, MD, FAAD, clinical assistant professor of dermatology and pediatrics at the Northwestern University Feinberg School of Medicine. Watch as Dr. Lio shares the burden of chronic hand eczem …